Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Mutant HSP70i protein may offer potent treatment opportunities for vitiligo

Loyola University Chicago Stritch School of Medicine researchers have developed a genetically modified protein that dramatically reverses the skin disorder vitiligo in mice, and has similar effects on immune responses in human skin tissue samples.

28 Feb 2013

Adolescents with joint hypermobility more likely to develop musculoskeletal pain

A prospective study by U.K. researchers found that adolescents who are double-jointed-medically termed joint hypermobility-are at greater risk for developing musculoskeletal pain as they get older, particularly in the shoulders, knees, ankles and feet.

28 Feb 2013

NYU Langone first in Northeast to use new device for surgical treatment of specific knee injuries

Orthopaedic surgeons and researchers at NYU Langone Medical Center are the first in the Northeast to use a new device that incorporates sensors, microelectronics and wireless communication to provide real-time data about positioning, balance and tension of ligaments during total knee replacement surgery.

28 Feb 2013

FDA accepts Antares Pharma's New Drug Application for OTREXUP

Antares Pharma, Inc. today announced that the New Drug Application for OTREXUP, a potential new product for the subcutaneous delivery of methotrexate using Medi-Jet technology, has been accepted by the U.S. Food and Drug Administration indicating that the application is sufficiently complete to permit a substantive review.

27 Feb 2013

Learned helplessness role in inflammatory polyarthritis revealed

Learned helplessness is a modifiable risk factor that can significantly influence disease outcome in patients with inflammatory polyarthritis, UK clinicians believe.

26 Feb 2013

Ampio to initiate dose escalation run-in study for treatment of knee osteoarthritis

Ampio Pharmaceuticals, Inc. announced today that it's Phase III clinical study of Ampion™ for the treatment for osteoarthritis of the knee will include a dose-escalation run-in study as recommended by the FDA.

25 Feb 2013

Researchers map complex interactions of proteins that control inflammation

Inflammatory response plays a major role in both health protection and disease generation. While the symptoms of disease-related inflammatory response have been know, scientists have not understood the mechanisms that underlie it.

25 Feb 2013

Team Danmark, Global Health Partner enter exclusive collaboration agreement

Through its subsidiary Gildhøj Privathospital, Global Health Partner is entering into an exclusive collaboration agreement with Team Danmark to provide Denmark's leading elite athletes with sports medicine and sports surgery.

22 Feb 2013

Study finds bariatric surgery does not reduce long-term medical costs

Research disputes widely-held beliefs that the weight-loss operations cut the need for treatments and medicine after patients shed pounds.

22 Feb 2013

New mouse model can advance research on iPS cells to next step

VIB scientists associated to the UGent have developed a mouse model that can advance the research on iPS cells to the next step.

21 Feb 2013

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB announced today two new regulatory filings with the US Food and Drug Administration (FDA) and with the European Medicines Agency (EMA) to extend the marketing authorization for Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA) and for adult patients with active axial spondyloarthritis (axSpA).

20 Feb 2013

Allergan receives FDA approval for Natrelle 410 breast implant

The U.S. Food and Drug Administration today approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.

20 Feb 2013

European Congress on Osteoporosis & Osteoarthritis to be held in Rome, Italy

The International Osteoporosis Foundation (IOF) and ESCEO have announced that a record number of abstracts (850+) have been submitted to the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) and the 3rd IOF-ESCEO Pre-Clinical Symposium.

20 Feb 2013

Targeting p38alpha MAPK isoform can help treat CNS inflammatory diseases

A study by a leading Alzheimer's researcher at the University of Kentucky provides new evidence that will help researchers home in on the molecular mechanisms involved in inflammation of the central nervous system (CNS) and aid drug-development strategies for treating inflammatory neurological diseases.

20 Feb 2013

Researchers suggest that fibromyalgia is a spectrum disorder

20 Feb 2013

Meloxicam recognizes and treats osteoarthritis in cats

Scientists at the University of Montreal's Quebec Research Group in Animal Pharmacology have found a way to recognize and treat osteoarthritis in cats - a condition that the owner might not notice and that can make even petting painful.

20 Feb 2013

Fibromyalgia prevalence is 2.1% of the general population in Germany

Researchers have determined that fibromyalgia prevalence is 2.1% of the general population in Germany. Results appearing in Arthritis Care & Research, a journal published by Wiley on behalf of the American College of Rheumatology (ACR), suggest that fibromyalgia is a spectrum disorder rather than a categorical illness. Additionally, a number of fibromyalgia cases in the general population satisfy proposed criteria for physical symptom disorder—the presence of one or more physical symptoms that impair function, which cannot be explained by another clinical or psychiatric illness.

19 Feb 2013

Antibody test ‘inappropriate’ without connective tissue symptoms

The positive antinuclear antibody test is often used inappropriately in patients without indications of connective tissue disease, real-world research suggests.

18 Feb 2013

Morning, smooth ambulatory BP control ‘rarely achieved’ in general practice

Most patients receiving treatment for hypertension do not have their morning blood pressure levels controlled, and do not achieve smooth daytime control, researchers report.

18 Feb 2013

Study identifies regions of genes linked to Beh-et's disease

Researchers don't know the exact cause of Beh-et's disease, a chronic condition that leads to oral and genital sores and serious complications such as blindness, but new research brings better understanding to what makes some people more susceptible to being affected.

16 Feb 2013